rs747678800
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_006005.3(WFS1):c.1552A>G(p.Met518Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000295 in 1,460,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M518I) has been classified as Likely benign.
Frequency
Consequence
NM_006005.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFS1 | NM_006005.3 | c.1552A>G | p.Met518Val | missense_variant | Exon 8 of 8 | ENST00000226760.5 | NP_005996.2 | |
WFS1 | NM_001145853.1 | c.1552A>G | p.Met518Val | missense_variant | Exon 8 of 8 | NP_001139325.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250510Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135518
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1460006Hom.: 0 Cov.: 99 AF XY: 0.0000303 AC XY: 22AN XY: 726402
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Met518Val variant in WFS1 has been reported in 1 Japanese individual with some of the clinical features of Wolfram Syndrome, who also carries a second var iant (p.Leu432Val) in WFS1 (Matsunaga 2014). The p.Met518Val variant has also be en identified in 2/66566 of European chromosomes by the Exome Aggregation Consor tium (ExAC, http://exac.broadinstitute.org); though this frequency is not high e nough to rule out a pathogenic role. However, it should be noted that another va riant at this amino acid residue (p.Met518Ile) has been identified in 0.6% (63/1 0382) of African American chromosomes by the Exome Aggregation Consortium, sugge sting that variation at this position may be tolerated (ExAC, http://exac.broadi nstitute.org; dbSNP rs138232538). In addition, the p.Leu432Val variant identifie d in the affected individual in Matasunaga et al. (2014) has been also identifie d in 358/66730 (0.5%) of European chromosomes by the Exome Aggregation Consortiu m (ExAC, http://exac.broadinstitute.org; dbSNP rs35031397) suggesting that this variant is benign and, therefore, making it unlikely that these variants are rel ated to the features seen in that individual. Computational prediction tools and conservation analysis of the p.Met518Val variant do not provide strong support for or against an impact to the protein. In summary, the clinical significance o f the p.Met518Val variant is uncertain. -
not provided Uncertain:1
Previously reported as heterozygous in an individual with diabetes mellitus, optic atrophy, and brain atrophy who was also heterozygous for a second variant in WFS1 (Matsunaga et al., 2014); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25211237) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at